ODT Odonate Therapeutics Inc.

Odonate Therapeutics Inc is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer.

As of 11/30/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  12/07/2017
Outstanding shares:  38,490,336
Average volume:  1,402,874
Market cap:   $63,509,054
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    676079106
ISIN:        US6760791060
Sedol:      BD1KGM3
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.91
PS ratio:   0.00
Return on equity:   -143.01%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy